Accumulating evidence indicates that elevated ULK1 expression has been observed in several human cancers, including esophageal squamous cell carcinoma, nasopharyngeal carcinoma, colorectal cancer [23], gastric cancer, hepatocellular carcinoma [24], and clear cell renal carcinoma [25]. Here, ULK1 is linked to hepatocellular carcinoma.